OtherHot Topics (Invitation Only)
The emergence of somatostatin antagonist-based theranostics: Paving the road toward another success?
Alessio Imperiale, Abhishek Jha, Leah Meuter, Guillaume P Nicolas, David Taïeb and Karel Pacak
Journal of Nuclear Medicine February 2023, jnumed.123.265406; DOI: https://doi.org/10.2967/jnumed.123.265406
Alessio Imperiale
1 Nuclear Medicine and Molecular Imaging, ICANS, Strasbourg University, France;
Abhishek Jha
2 Eunice Kennedy Shriver NICHD, National Institutes of Health, United States;
Leah Meuter
2 Eunice Kennedy Shriver NICHD, National Institutes of Health, United States;
Guillaume P Nicolas
3 Div. of Nuclear Medicine, Center for Neuroendocrine and Endocrine Tumors, University Hospital Basel, Switzerland;
David Taïeb
4 La Timone University Hospital, CERIMED, Aix-Marseille University
Karel Pacak
2 Eunice Kennedy Shriver NICHD, National Institutes of Health, United States;
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
The emergence of somatostatin antagonist-based theranostics: Paving the road toward another success?
Alessio Imperiale, Abhishek Jha, Leah Meuter, Guillaume P Nicolas, David Taïeb, Karel Pacak
Journal of Nuclear Medicine Feb 2023, jnumed.123.265406; DOI: 10.2967/jnumed.123.265406
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.